The Effect of Laparoscopic Splenectomy and Azygoportal Disconnection on the Immune Function for Cirrhosis Patients

Northern Jiangsu People's Hospital20 enrolled

Overview

In this study, the investigators compared the improvement of immune function related indicators in patients with liver cirrhosis after laparoscopic splenectomy and azygoportal disconnection. To determine whether surgical treatment can help enhance postoperative immune function and improve patient prognosis.

The patients were enrolled according to the research criteria, and collected the general basic information of the patients. After the preoperative preparation was perfected, the same surgical team performed laparoscopic splenectomy and azygoportal disconnection, and the same nursing team performed the nursing after the operation. Then, patients received a unified treatment plan after surgery, including medication, other treatments and follow-up. During the treatment, the immune function related indicators of the patients were monitored before surgery, 3, 6, 12 and 24 months after surgery, including the counts of leukocytes, neutrophils, lymphocytes, and monocytes, and the levels of CD4+,CD8+,CD4+/CD8+, and CD19,CD20.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Cirrhosis, Liver Splenectomy; Status

Interventions

Laparoscopic splenectomy and azygoportal disconnectionPROCEDURE

Laparoscopic splenectomy and azygoportal disconnection is performed by the same surgical team.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * A clinical, radiological or histologic diagnosis of cirrhosis of any etiology * Splenomegaly with secondary hypersplenism * gastroesophageal variceal bleeding * Informed consent to participate in the study Exclusion Criteria: * Hepatocellular carcinoma or any other malignancy, * Child-Pugh grade C * Recent peptic ulcer disease * History of Hemorrhagic stroke * Pregnancy. * Uncontrolled Hypertension * Human immunodeficiency virus (HIV) infection

Locations (1)

Clinical Medical College, Yangzhou University

Yangzhou, Jiangsu, China

RECRUITING

Outcomes

Primary Outcomes

The immune function CD4+ at 3 months after surgery

The level of the immune function CD4+ at 3 months after surgery

Time frame: 3 months

The immune function CD4+ at 6 months after surgery

The level of the immune function CD4+ at 6 months after surgery

Time frame: 6 months

The immune function CD4+ at 12 months after surgery

The level of the immune function CD4+ at 12 months after surgery

Time frame: 12 months

The immune function CD4+ at 24 months after surgery

The level of the immune function CD4+ at 24 months after surgery

Time frame: 24 months

The immune function CD8+ at 3 months after surgery

The level of the immune function CD8+ at 3 months after surgery

Time frame: 3 months

The immune function CD8+ at 6 months after surgery

The level of the immune function CD8+ at 6 months after surgery

Time frame: 6 months

The immune function CD8+ at 12 months after surgery

The level of the immune function CD8+ at 12 months after surgery

Time frame: 12 months

The immune function CD8+ at 24 months after surgery

The level of the immune function CD8+ at 24 months after surgery

Time frame: 24 months

The immune function CD4+/CD8+ at 3 months after surgery

Central Contacts

Guo-Qing Jiang, MD

CONTACT

+8651487373382 jgqing2003@hotmail.com

Dou-Sheng Bai, MD

CONTACT

+8651487373382 jgqing2003@hotmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.